How effective is atezolizumab treatment?

As a PD-L1 inhibitor, atezolizumab has demonstrated definite efficacy in treating various malignant tumors, capable of prolonging survival and controlling tumor progression in some patients, with a favorable safety profile. If symptoms such as persistent fever, severe rash, or difficulty breathing occur, prompt medical attention is recommended.

Atezolizumab works by blocking the interaction between PD-L1 and PD-1, thereby releasing the inhibition of tumor cells on the immune system and activating the body's own immune cells to attack tumors. It is indicated for various solid tumors, including non-small cell lung cancer, bladder cancer, and triple-negative breast cancer.

Clinical data show that in patients with PD-L1-positive tumors, both objective response rates and progression-free survival are significantly improved. Particularly in the treatment of advanced cancers, atezolizumab can serve as either a first-line or second-line therapy, offering meaningful survival benefits.

During treatment, patients should maintain regular作息 (daily routines), avoid fatigue, follow a light and easily digestible diet to ensure adequate nutrition, maintain skin hygiene to prevent infection, closely monitor bodily reactions, strictly adhere to medical instructions throughout the treatment course, and must not adjust doses or discontinue medication without authorization.